Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapy for esthesioneuroblastomas.

J M Sheehan1, J P Sheehan, J A Jane

  • 1Department of Neurosurgery, University of Virginia Health Sciences Center, Charlottesville 22908, USA.

Neurosurgery Clinics of North America
|November 18, 2000
PubMed
Summary

Esthesioneuroblastoma is a chemosensitive tumor, with platinum-based neoadjuvant therapy showing promise. While not always curative, preoperative treatment improves long-term survival for responsive patients with this rare cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cauda equina compression following epidural injection for disc prolapse.

Irish journal of medical science·2016
Same author

Epidural Hematoma in Lacrosse.

The Physician and sportsmedicine·2016
Same author

L-Arginine supplementation 0.5% of diet during the last 90 days of gestation and 14 days postpartum reduced uterine fluid accumulation in the broodmare.

Animal reproduction science·2015
Same author

Selective disruption of heparin and antithrombin-mediated regulation of human factor IX.

Journal of thrombosis and haemostasis : JTH·2015
Same author

Determining need for treatment in residual pituitary adenomas.

Journal of neurosurgical sciences·2015
Same author

Preoperative embolization of intracranial meningiomas: efficacy, technical considerations, and complications.

AJNR. American journal of neuroradiology·2014

Area of Science:

  • Oncology
  • Head and Neck Surgery
  • Medical Oncology

Background:

  • Esthesioneuroblastoma is recognized as a chemosensitive malignancy.
  • Current treatment strategies often involve neoadjuvant or adjuvant chemotherapy.
  • The rarity of esthesioneuroblastoma presents challenges in establishing treatment consensus.

Purpose of the Study:

  • To review the role of chemotherapy in the management of esthesioneuroblastoma.
  • To evaluate the impact of neoadjuvant therapy on patient outcomes.
  • To discuss current standards of care for advanced or recurrent esthesioneuroblastoma.

Main Methods:

  • Review of existing literature on esthesioneuroblastoma treatment.
  • Analysis of treatment response and survival data.

Related Experiment Videos

  • Discussion of platinum-based chemotherapy regimens.

    • Main Results:

    • Esthesioneuroblastoma demonstrates sensitivity to chemotherapy.
    • Neoadjuvant therapy, while not universally curative, is associated with improved long-term disease-free survival in responders.
    • Platinum-based chemotherapy is the primary treatment modality with generally mild toxicity.

    Conclusions:

    • Preoperative or postoperative chemotherapy is the established standard of care for advanced or recurrent esthesioneuroblastoma.
    • Patient response to neoadjuvant therapy is a significant predictor of long-term outcomes.
    • Further research is needed, but current evidence supports chemotherapy's role in managing this rare tumor.